Cytopathology and More | Inside the 2014 Bethesda System for Reporting Cervical Cytology

Create PDF

1. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA. 1989;262(7):931–934.
2. Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17(5 suppl 1):S1–S27.
3. Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol. 2000;44(5):726–742.
4. Ali SZ, Cibas ES, eds. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes. New York: Springer; 2010.
5. Layfield LJ, Pitman MB, DeMay RM, Shidham VB. Pancreaticobiliary tract cytology: journey toward “Bethesda” style guidelines from the Papanicolaou Society of Cytopathology. Cytojournal. 2014;11:18.
6. Rosenthal D, Wojcik E. The ASC Companion Meeting at the 2014 USCAP: the quest for standardization of urine cytology reporting—the evolution of the Paris System. J Am Soc Cytopathol. 2014;3:II–III.
7. Darragh TM, Colgan TJ, Cox JT, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med. 2012;136(10):1266–1297.
8. Nayar R, Wilbur DC, eds. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. 3rd ed. Cham, Switzerland: Springer; 2015.
9. Bethesda System Website Atlas. nih.techriver.net. Accessed April 14, 2015.
10. Sherman ME, Dasgupta A, Schiffman M, Nayar R, Solomon D. The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytology. Cancer Cytopathol. 2007;111(1):15–25.
11. Nayar R, Wilbur DC. The Pap test and Bethesda 2014. Epub ahead of print May 1, 2015. Cancer Cytopathol. doi:10.1002/cncy.21521.

Dr. Nayar and Dr. Kurtycz are members of the CAP Cytopathology Committee. Dr. Nayar was the 2013–2014 ASC president. Members of the Bethesda 2014 Atlas Task Force are as follows: Dr. Wilbur and Dr. Nayar (co-chairs); Dr. Solomon (advisor); Dr. Kurtycz; Fadi W. Abdul-Karim, MD; George G. Birdsong, MD; David Chelmow, MD; David C. Chhieng, MD; Edmund S. Cibas, MD; Teresa M. Darragh, MD; Diane D. Davey, MD; Michael R. Henry, MD; Walid E. Khalbuss, MD, PhD; Dina R. Mody, MD; Ann T. Moriarty, MD; Joel M. Palefsky, MD; Celeste N. Powers, MD, PhD; Donna K. Russell, MEd, CT(ASCP), HT(ASCP); Mark Schiffman, MD, MPH; Mary K. Sidawy, MD; Paul N. Staats, MD; Mark H. Stoler, MD; Sana O. Tabbara, MD; Alan G. Waxman, MD; and Nicolas Wentzensen, MD, PhD.

The 2014 Bethesda Website Task Force members are Dr. Kurtycz and Dr. Staats (co-chairs); Dr. Nayar and Dr. Wilbur (advisors); Deborah Chute, MD; Maria Freidlander, MPA, CT(ASCP); Sara Monaco, MD; Donna K. Russell, MEd, CT(ASCP).

Springer will release the atlas as a soft-cover print version and an online ebook. Cost in the U.S. is $49.99 for the print version and $39.99 for the electronic version (www.springer.com/us/book/9783319110738).